Generic Drug Makers Resisting Reform
The Generic Pharmaceutical Industry Association (GPIA) has released a statement opposing the recently approved bill that will require them to pay substantial rebates to state and federal Medicaid programs as a part of health care reform. The bill, which passed last week in the Senate Finance Committee, requires generic drug makers to pay $460 million […]
